{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T17:08:53Z","timestamp":1774458533594,"version":"3.50.1"},"reference-count":133,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T00:00:00Z","timestamp":1662940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Stevens\u2013Johnson syndrome and toxic epidermal necrolysis (SJS\/TEN) are on a spectrum of cutaneous drug reactions characterized by pan-epidermal necrosis with SJS affecting &amp;lt; 10% of body surface area (BSA), TEN &amp;gt; 30%, and SJS\/TEN overlap between 10 and 30%. Severity-of-illness score for toxic epidermal necrolysis (SCORTEN) is a validated tool to predict mortality rates based on age, heart rate, BSA, malignancy and serum urea, bicarbonate, and glucose. Despite improved understanding, SJS\/TEN mortality remains constant and therapeutic interventions are not universally accepted for a number of reasons, including rarity of SJS\/TEN; inconsistent definition of cases, disease severity, and endpoints in studies; low efficacy of interventions; and variations in treatment protocols. Apart from mortality, none of the other endpoints used to evaluate interventions, including duration of hospitalization, is sufficiently standardized to be reproducible across cases and treatment centers. Some of the gaps in SJS\/TEN research can be narrowed through international collaboration to harmonize research endpoints. A case is made for an urgent international collaborative effort to develop consensus on definitions of endpoints such as disease status, progression, cessation, and complete re-epithelialization in interventional studies. The deficiencies of using BSA as the sole determinant of SJS\/TEN severity, excluding internal organ involvement and extension of skin necrosis beyond the epidermis, are discussed and the role these factors play on time to healing and mortality beyond the acute stage is highlighted. The potential role of artificial intelligence, biomarkers, and PET\/CT scan with radiolabeled glucose as markers of disease status, activity, and therapeutic response is also discussed.<\/jats:p>","DOI":"10.3389\/fmed.2022.901401","type":"journal-article","created":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T06:02:59Z","timestamp":1662962579000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Disease severity and status in Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: Key knowledge gaps and research needs"],"prefix":"10.3389","volume":"9","author":[{"given":"Rannakoe J.","family":"Lehloenya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1001\/archderm.129.1.92","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme.","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/01.BCR.0000105096.93526.27","article-title":"Toxic epidermal necrolysis: does immunoglobulin make a difference?","volume":"25","author":"Brown","year":"2004","journal-title":"J Burn Care Rehabil."},{"key":"B3","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"SCORTEN: a severity-of-illness score for toxic epidermal necrolysis.","volume":"115","author":"Bastuji-Garin","year":"2000","journal-title":"J Invest Dermatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1001\/jamadermatol.2020.3654","article-title":"Assessment and comparison of performance of ABCD-10 and SCORTEN in prognostication of epidermal necrolysis.","volume":"156","author":"Koh","year":"2020","journal-title":"JAMA Dermatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.jid.2017.01.003","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: associations, outcomes, and pathobiology-thirty years of progress but still much to be done.","volume":"137","author":"Stern","year":"2017","journal-title":"J Invest Dermatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1001\/jamadermatol.2016.5668","article-title":"Systemic immunomodulating therapies for Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis.","volume":"153","author":"Zimmermann","year":"2017","journal-title":"JAMA Dermatol."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013130.pub2","article-title":"Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS\/TEN overlap syndrome.","volume":"3","author":"Jacobsen","year":"2022","journal-title":"Cochrane Database Syst Rev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.jaad.2018.06.002","article-title":"Minimal clinically important differences for measures of treatment efficacy in Stevens-Johnson syndrome and toxic epidermal necrolysis.","volume":"79","author":"Kim","year":"2018","journal-title":"J Am Acad Dermatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.burns.2021.11.004","article-title":"Impact of multiple medical interventions on mortality, length of hospital stay and reepithelialization time in toxic epidermal necrolysis, Steven-Johnsons syndrome, and TEN\/SJS overlap \u2013 Metanalysis and metaregression of observational studies.","volume":"48","author":"Krajewski","year":"2022","journal-title":"Burns."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.12968\/jowc.2021.30.12.1012","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis.","volume":"30","author":"Houschyar","year":"2021","journal-title":"J Wound Care."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.jaad.2022.01.039","article-title":"Inhibition of tumor necrosis factor improves conventional steroid therapy for Stevens-Johnson syndrome\/toxic epidermal necrolysis in a cohort of patients.","volume":"86","author":"Ao","year":"2022","journal-title":"J Am Acad Dermatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.jaip.2022.01.038","article-title":"Evaluation of combination therapy with etanercept and systemic corticosteroids for Stevens-Johnson syndrome and toxic epidermal necrolysis: a multicenter observational study.","volume":"10","author":"Zhang","year":"2022","journal-title":"J Allergy Clin Immunol Pract."},{"key":"B13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/978-1-0716-2265-0_3","article-title":"Stevens-Johnson Syndrome and toxic epidermal necrolysis in the era of systems medicine.","volume":"2486","author":"Chen","year":"2022","journal-title":"Methods Mol Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jaad.2013.11.015","article-title":"Generalized bullous fixed drug eruption is distinct from Stevens-Johnson syndrome\/toxic epidermal necrolysis by immunohistopathological features.","volume":"70","author":"Cho","year":"2014","journal-title":"J Am Acad Dermatol."},{"key":"B15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jdermsci.2020.02.003","article-title":"SJS\/TEN 2019: from science to translation.","volume":"98","author":"Chang","year":"2020","journal-title":"J Dermatol Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jaip.2017.11.028","article-title":"SJS\/TEN 2017: building multidisciplinary networks to drive science and translation.","volume":"6","author":"White","year":"2018","journal-title":"J Allergy Clin Immunol Pract."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1001\/jamadermatol.2021.3154","article-title":"Assessment of treatment approaches and outcomes in Stevens-Johnson syndrome and toxic epidermal necrolysis: insights from a pan-european multicenter study.","volume":"157","author":"Kridin","year":"2021","journal-title":"JAMA Dermatol."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1186\/cc6141","article-title":"Dermatological conditions in intensive care: a secondary analysis of the Intensive Care National Audit and Research Centre (ICNARC) case mix programme database.","volume":"12","author":"George","year":"2008","journal-title":"Crit Care."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1038\/jid.2012.510","article-title":"Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.","volume":"133","author":"Sekula","year":"2013","journal-title":"J Invest Dermatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1111\/j.1468-3083.2012.04667.x","article-title":"Toxic epidermal necrolysis with failure of re-epithelialization. Could umbilical cord mesenchymal stem cell transplantation have a role?","volume":"27","author":"Lehloenya","year":"2013","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.iac.2022.01.005","article-title":"Recognizing drug hypersensitivity in pigmented skin.","volume":"42","author":"Lehloenya","year":"2022","journal-title":"Immunol Allergy Clin North Am."},{"key":"B22","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1172\/JCI93349","article-title":"Randomized, controlled trial of TNF-alpha antagonist in CTL-mediated severe cutaneous adverse reactions.","volume":"128","author":"Wang","year":"2018","journal-title":"J Clin Invest."},{"key":"B23","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/j.1365-2133.2010.09863.x","article-title":"Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis.","volume":"163","author":"Valeyrie-Allanore","year":"2010","journal-title":"Br J Dermatol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2500\/108854100778250914","article-title":"Corticosteroid therapy in an additional 13 cases of Stevens-Johnson syndrome: a total series of 67 cases.","volume":"21","author":"Tripathi","year":"2000","journal-title":"Allergy Asthma Proc."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/S0140-6736(98)02197-7","article-title":"Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis.","volume":"352","author":"Wolkenstein","year":"1998","journal-title":"Lancet."},{"key":"B26","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.burns.2006.04.031","article-title":"Delayed reepithelialization and scarring deregulation following drug-induced toxic epidermal necrolysis.","volume":"33","author":"Paquet","year":"2007","journal-title":"Burns."},{"key":"B27","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/bjd.17627","article-title":"Dark skin phototype is associated with more severe ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.","volume":"181","author":"Thorel","year":"2019","journal-title":"Br J Dermatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1001\/jamadermatol.2019.0998","article-title":"Development and validation of a risk prediction model for in-hospital mortality among patients with Stevens-Johnson syndrome\/toxic epidermal necrolysis-ABCD-10.","volume":"155","author":"Noe","year":"2019","journal-title":"JAMA Dermatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1097\/BCR.0000000000000328","article-title":"Not all drugs are created equal: the importance of causative agent in toxic epidermal necrolysis.","volume":"37","author":"Cooney","year":"2016","journal-title":"J Burn Care Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1001\/archderm.123.9.1160","article-title":"Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients.","volume":"123","author":"Revuz","year":"1987","journal-title":"Arch Dermatol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1016\/j.jaad.2021.01.072","article-title":"Disseminated intravascular coagulation in Stevens-Johnson syndrome and toxic epidermal necrolysis.","volume":"84","author":"Chen","year":"2021","journal-title":"J Am Acad Dermatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1111\/1346-8138.14488","article-title":"Procalcitonin as a diagnostic indicator for systemic bacterial infections in patients with Stevens-Johnson syndrome\/toxic epidermal necrolysis.","volume":"45","author":"Wang","year":"2018","journal-title":"J Dermatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jaad.2019.03.030","article-title":"Incidence of bloodstream infections and predictive value of qualitative and quantitative skin cultures of patients with overlap syndrome or toxic epidermal necrolysis: a retrospective observational cohort study of 98 cases.","volume":"81","author":"Lecadet","year":"2019","journal-title":"J Am Acad Dermatol."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093543","article-title":"Factors associated with increased mortality in a predominantly HIV-infected population with Stevens Johnson syndrome and toxic epidermal necrolysis.","volume":"9","author":"Knight","year":"2014","journal-title":"PLoS One."},{"key":"B35","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/00004630-198305000-00005","article-title":"Clinical management: a burn center experience with toxic epidermal necrolysis.","volume":"4","author":"Halebian","year":"1983","journal-title":"J Burn Care Rehabil."},{"key":"B36","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/0016-5085(86)90585-8","article-title":"Gastrointestinal involvement complicating Stevens-Johnson syndrome.","volume":"91","author":"Zweiban","year":"1986","journal-title":"Gastroenterology."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1177\/014556130208100408","article-title":"Stevens-Johnson syndrome with diffuse esophageal involvement.","volume":"81","author":"Belafsky","year":"2002","journal-title":"Ear Nose Throat J."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1007\/BF01296123","article-title":"Ileal involvement in toxic epidermal necrolysis (Lyell syndrome).","volume":"38","author":"Michel","year":"1993","journal-title":"Dig Dis Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0190-9622(08)81810-5","article-title":"Esophageal necrosis in the Stevens-Johnson syndrome.","volume":"29","author":"Mahe","year":"1993","journal-title":"J Am Acad Dermatol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/ped.13613","article-title":"Clinical features of Stevens-Johnson syndrome and toxic epidermal necrolysis.","volume":"60","author":"Sato","year":"2018","journal-title":"Pediatr Int."},{"key":"B41","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.alit.2015.09.001","article-title":"Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients\u2013Treatment and outcome.","volume":"65","author":"Yamane","year":"2016","journal-title":"Allergol Int."},{"key":"B42","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/1346-8138.13040","article-title":"Clinical profiles and treatment outcomes of systemic corticosteroids for toxic epidermal necrolysis: a retrospective study.","volume":"43","author":"Choonhakarn","year":"2016","journal-title":"J Dermatol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2174\/1574886309666140827122735","article-title":"Paracetamol-induced Stevens Johnson syndrome and cholestatic hepatitis.","volume":"10","author":"Slim","year":"2015","journal-title":"Curr Drug Saf."},{"key":"B44","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/1346-8138.12499","article-title":"Clinical profiles of Stevens-Johnson syndrome among Thai patients.","volume":"41","author":"Limpawattana","year":"2014","journal-title":"J Dermatol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/000360129","article-title":"Perforated sigmoid diverticulitis in the presence of toxic epidermal necrolysis.","volume":"6","author":"Heye","year":"2014","journal-title":"Case Rep Dermatol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e346","DOI":"10.1097\/BCR.0000000000000006","article-title":"Mesenteric ischemia secondary to toxic epidermal necrolysis: case report and review of the literature.","volume":"35","author":"Pradka","year":"2014","journal-title":"J Burn Care Res."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1443-1661.2012.01248.x","article-title":"Colonic involvement in Stevens-Johnson syndrome: a rare entity.","volume":"24","author":"Jha","year":"2012","journal-title":"Dig Endosc."},{"key":"B48","first-page":"S85","article-title":"Stevens-Johnson syndrome in Thai children: a 29-year study.","volume":"9","author":"Singalavanija","year":"2011","journal-title":"J Med Assoc Thai."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1016\/j.jpedsurg.2010.09.011","article-title":"Toxic epidermal necrolysis complicated by small bowel intussusception: a case report.","volume":"46","author":"Bouziri","year":"2011","journal-title":"J Pediatr Surg."},{"key":"B50","first-page":"1353","article-title":"[A case of toxic epidermal necrolysis with severe intestinal manifestation].","volume":"105","author":"Otomi","year":"2008","journal-title":"Nihon Shokakibyo Gakkai Zasshi."},{"key":"B51","doi-asserted-by":"publisher","first-page":"419","DOI":"10.2332\/allergolint.O-07-483","article-title":"Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan from 2000 to 2006.","volume":"56","author":"Yamane","year":"2007","journal-title":"Allergol Int."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2005.042952","article-title":"Colonic involvement in Stevens-Johnson syndrome.","volume":"82","author":"Powell","year":"2006","journal-title":"Postgrad Med J."},{"key":"B53","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.gie.2005.06.034","article-title":"A case of toxic epidermal necrolysis with involvement of the GI tract after systemic contrast agent application at cardiac catheterization.","volume":"62","author":"Garza","year":"2005","journal-title":"Gastrointest Endosc."},{"key":"B54","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0016-5107(03)02710-X","article-title":"Esophageal stricture as a late sequel of Stevens-Johnson syndrome in adults: incidental detection because of foreign body impaction.","volume":"59","author":"Misra","year":"2004","journal-title":"Gastrointest Endosc."},{"key":"B55","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1023\/A:1012351231143","article-title":"Stevens-Johnson Syndrome and cholestatic hepatitis.","volume":"46","author":"Morelli","year":"2001","journal-title":"Dig Dis Sci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1542\/peds.89.3.429","article-title":"Unusual manifestation of Stevens-Johnson syndrome involving the respiratory and gastrointestinal tract.","volume":"89","author":"Edell","year":"1992","journal-title":"Pediatrics."},{"key":"B57","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000234043","article-title":"Toxic epidermal necrolysis with extensive mucosal erosions of the gastrointestinal and respiratory tracts.","volume":"80","author":"Roupe","year":"1986","journal-title":"Int Arch Allergy Appl Immunol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S0190-9622(85)80012-8","article-title":"Phenytoin hypersensitivity reaction presenting with toxic epidermal necrolysis and severe hepatitis. Report of a patient treated with corticosteroid \u201cpulse therapy\u201d.","author":"Sherertz","year":"1985","journal-title":"J Am Acad Dermatol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s001340050492","article-title":"Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study.","volume":"23","author":"Lebargy","year":"1997","journal-title":"Intensive Care Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/CCM.0b013e31829eb94f","article-title":"Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilation.","volume":"42","author":"de Prost","year":"2014","journal-title":"Crit Care Med."},{"key":"B61","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/bjd.13505","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: follow-up of pulmonary function after remission.","volume":"172","author":"Duong","year":"2015","journal-title":"Br J Dermatol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/ced.13969","article-title":"Bronchiolitis obliterans as a long-term sequela of Stevens-Johnson syndrome and toxic epidermal necrolysis in children.","volume":"44","author":"Seccombe","year":"2019","journal-title":"Clin Exp Dermatol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"525","DOI":"10.2340\/00015555-2295","article-title":"Long-term sequelae of Stevens-Johnson syndrome\/toxic epidermal necrolysis.","volume":"96","author":"Yang","year":"2016","journal-title":"Acta Derm Venereol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.burns.2015.03.012","article-title":"Complications of Stevens-Johnson syndrome beyond the eye and skin.","volume":"42","author":"Saeed","year":"2016","journal-title":"Burns."},{"key":"B65","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jfma.2012.02.026","article-title":"Bronchiolitis obliterans complicating a pneumothorax after Stevens-Johnson syndrome induced by lamotrigine.","volume":"114","author":"Wang","year":"2015","journal-title":"J Formos Med Assoc."},{"key":"B66","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3349\/ymj.2015.56.2.578","article-title":"Bronchiolitis obliterans associated with Stevens-Johnson syndrome: a case report.","volume":"56","author":"Park","year":"2015","journal-title":"Yonsei Med J."},{"key":"B67","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1179\/2295333714Y.0000000086","article-title":"Chronic respiratory failure due to toxic epidermal necrosis in a 10 year old girl.","volume":"70","author":"Thimmesch","year":"2015","journal-title":"Acta Clin Belg."},{"key":"B68","doi-asserted-by":"publisher","first-page":"E130","DOI":"10.1002\/ppul.22908","article-title":"An atypical presentation of pulmonary air-leak syndrome and multisystem toxic epidermal necrolysis.","volume":"49","author":"Ellenburg","year":"2014","journal-title":"Pediatr Pulmonol."},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1186\/1746-1596-8-134","article-title":"Bronchiolitis obliterans associated with Stevens-Johnson syndrome: histopathological bronchial reconstruction of the whole lung and immunohistochemical study.","volume":"8","author":"Sugino","year":"2013","journal-title":"Diagn Pathol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/1346-8138.12136","article-title":"Adult case of Stevens-Johnson syndrome possibly induced by Chlamydophila pneumoniae infection with severe involvement of bronchial epithelium resulting in constructive respiratory disorder.","volume":"40","author":"Tanaka","year":"2013","journal-title":"J Dermatol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.2169\/internalmedicine.50.5582","article-title":"Severe obliterative bronchitis associated with Stevens-Johnson syndrome.","volume":"50","author":"Woo","year":"2011","journal-title":"Intern Med."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1183\/09031936.00036006","article-title":"Severe airflow obstruction and eosinophilic lung disease after Stevens-Johnson syndrome.","volume":"28","author":"Shah","year":"2006","journal-title":"Eur Respir J."},{"key":"B73","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/j.1346-8138.2006.00142.x","article-title":"Chronic pulmonary complications associated with toxic epidermal necrolysis: report of a severe case with anti-Ro\/SS-A and a review of the published work.","volume":"33","author":"Kamada","year":"2006","journal-title":"J Dermatol."},{"key":"B74","first-page":"839","article-title":"[Clinical feature of four cases with bronchiolitis obliterans].","volume":"41","author":"Liu","year":"2003","journal-title":"Zhonghua Er Ke Za Zhi."},{"key":"B75","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S1695-4033(02)77897-1","article-title":"[Fatal respiratory and renal manifestation of Stevens-Johnson syndrome. Pathological anatomical study].","volume":"57","author":"Garcia Suarez","year":"2002","journal-title":"An Esp Pediatr."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1001\/archotol.1989.01860350115026","article-title":"Stevens-Johnson syndrome with supraglottic laryngeal obstruction.","volume":"115","author":"Koch","year":"1989","journal-title":"Arch Otolaryngol Head Neck Surg."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.4103\/0366-6999.204929","article-title":"Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 88 Chinese patients.","volume":"130","author":"Wang","year":"2017","journal-title":"Chin Med J (Engl)."},{"key":"B78","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1016\/j.jaip.2019.05.047","article-title":"Unique clinical characteristics and prognosis of allopurinol-induced severe cutaneous adverse reactions.","volume":"7","author":"Park","year":"2019","journal-title":"J Allergy Clin Immunol Pract."},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0203642","article-title":"The influence of acute kidney injury on the outcome of Stevens-Johnson syndrome and toxic epidermal necrolysis: the prognostic value of KDIGO staging.","volume":"13","author":"Lee","year":"2018","journal-title":"PLoS One."},{"key":"B80","doi-asserted-by":"publisher","first-page":"e265","DOI":"10.1097\/BCR.0b013e31829a4374","article-title":"The first reported case of ureteral perforation in a patient with severe toxic epidermal necrolysis syndrome.","volume":"35","author":"Baccaro","year":"2014","journal-title":"J Burn Care Res."},{"key":"B81","first-page":"354","article-title":"Severe gynecologic sequelae of Stevens-Johnson syndrome and toxic epidermal necrolysis caused by ibuprofen: a case report.","volume":"58","author":"Pliskow","year":"2013","journal-title":"J Reprod Med."},{"key":"B82","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.urology.2012.06.051","article-title":"Acquired labial sinechiae and hydrocolpos secondary to Stevens-Johnson syndrome.","volume":"80","author":"de Jesus","year":"2012","journal-title":"Urology."},{"key":"B83","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1111\/j.1468-3083.2006.01586.x","article-title":"Vaginal adenosis induced by Stevens-Johnson syndrome.","volume":"20","author":"Emberger","year":"2006","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S1083-3188(02)00146-8","article-title":"Vaginal adhesions caused by Stevens-Johnson syndrome.","volume":"15","author":"Hart","year":"2002","journal-title":"J Pediatr Adolesc Gynecol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/S0190-9622(96)90297-2","article-title":"Renal involvement in toxic epidermal necrolysis.","volume":"34","author":"Blum","year":"1996","journal-title":"J Am Acad Dermatol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1365-2230.1990.tb02112.x","article-title":"Introital adenosis associated with the Stevens-Johnson syndrome.","volume":"15","author":"Bonafe","year":"1990","journal-title":"Clin Exp Dermatol."},{"key":"B87","first-page":"478","article-title":"Vulvovaginal sequelae of Stevens-Johnson syndrome and their management.","author":"Wilson","year":"1988","journal-title":"Obstet Gynecol."},{"key":"B88","first-page":"143","article-title":"Introital adenosis associated with Stevens-Johnson syndrome.","volume":"66","author":"Marquette","year":"1985","journal-title":"Obstet Gynecol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1111\/j.1471-0528.1981.tb01772.x","article-title":"Vaginal stenosis due to bullous erythema multiforme (Stevens-Johnson syndrome). Case report.","volume":"88","author":"Graham-Brown","year":"1981","journal-title":"Br J Obstet Gynaecol."},{"key":"B90","first-page":"688","article-title":"[Endometriosis of obstetrical vulvo-vaginal cicatrices].","volume":"23","author":"Lerat","year":"1971","journal-title":"Bull Fed Soc Gynecol Obstet Lang Fr."},{"key":"B91","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/jdv.16891","article-title":"Chronic pain: a long-term sequela of epidermal necrolysis (Stevens-Johnson syndrome\/toxic epidermal necrolysis) \u2013 Prevalence, clinical characteristics and risk factors.","volume":"35","author":"Lefaucheur","year":"2021","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s40264-017-0608-0","article-title":"Severe physical complications among survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis.","volume":"41","author":"Olteanu","year":"2018","journal-title":"Drug Saf."},{"key":"B93","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1111\/bjd.15360","article-title":"Long-term complications of Stevens-Johnson syndrome\/toxic epidermal necrolysis (SJS\/TEN): the spectrum of chronic problems in patients who survive an episode of SJS\/TEN necessitates multidisciplinary follow-up.","volume":"177","author":"Lee","year":"2017","journal-title":"Br J Dermatol."},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0260730","article-title":"Multi-state model for predicting ocular progression in acute Stevens-Johnson syndrome\/toxic epidermal necrolysis.","volume":"16","author":"Kinoshita","year":"2021","journal-title":"PLoS One."},{"key":"B95","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jcrc.2017.07.002","article-title":"Successful treatment of toxic epidermal necrolysis using plasmapheresis: a prospective observational study.","volume":"42","author":"Han","year":"2017","journal-title":"J Crit Care."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/j.burns.2014.01.027","article-title":"Effect of N-acetylcysteine combined with infliximab on toxic epidermal necrolysis. A proof-of-concept study.","volume":"40","author":"Paquet","year":"2014","journal-title":"Burns."},{"key":"B97","doi-asserted-by":"publisher","first-page":"123","DOI":"10.12793\/tcp.2019.27.4.123","article-title":"Treatment response and disease progression.","volume":"27","author":"Holford","year":"2019","journal-title":"Transl Clin Pharmacol."},{"key":"B98","first-page":"158","article-title":"Role of systemic steroids in the outcome of Stevens-Johnson syndrome and toxic epidermal necrolysis.","volume":"20","author":"Azfar","year":"2010","journal-title":"J Pak Assoc Dermatol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"506","DOI":"10.4103\/0378-6323.113080","article-title":"Low dose intravenous immunoglobulins and steroids in toxic epidermal necrolysis: a prospective comparative open-labelled study of 36 cases.","volume":"79","author":"Jagadeesan","year":"2013","journal-title":"Indian J Dermatol Venereol Leprol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s004310050561","article-title":"Corticosteroid treatment of erythema multiforme major (Stevens-Johnson syndrome) in children.","volume":"156","author":"Kakourou","year":"1997","journal-title":"Eur J Pediatr."},{"key":"B101","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1016\/j.jid.2017.05.022","article-title":"Cyclosporine use in epidermal necrolysis is associated with an important mortality reduction: evidence from three different approaches.","volume":"137","author":"Gonzalez-Herrada","year":"2017","journal-title":"J Invest Dermatol."},{"key":"B102","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective study of epidemiology and clinical course.","volume":"68","author":"Agrawal","year":"2013","journal-title":"Allergy."},{"key":"B103","doi-asserted-by":"publisher","first-page":"894","DOI":"10.7196\/SAMJ.2015.v105i11.10180","article-title":"Appropriate indications for positron emission tomography\/computed tomography: College of Nuclear Physicians of the Colleges of Medicine of South Africa.","volume":"105","author":"Sathekge","year":"2015","journal-title":"S Afr Med J."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.2967\/jnumed.117.191635","article-title":"Metabolic imaging of infection.","volume":"58","author":"Lawal","year":"2017","journal-title":"J Nucl Med."},{"key":"B105","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1097\/QCO.0000000000000781","article-title":"Echocardiography and FDG-PET\/CT scan in gram-negative bacteremia and cardiovascular infections.","volume":"34","author":"Dahl","year":"2021","journal-title":"Curr Opin Infect Dis."},{"key":"B106","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1053\/j.semnuclmed.2021.06.017","article-title":"FDG-PET\/CT of COVID-19 and other lung infections.","volume":"52","author":"Eibschutz","year":"2022","journal-title":"Semin Nucl Med."},{"key":"B107","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1053\/j.semnuclmed.2021.06.008","article-title":"Limitations and pitfalls of FDG-PET\/CT in infection and inflammation.","volume":"51","author":"Pijl","year":"2021","journal-title":"Semin Nucl Med."},{"key":"B108","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1053\/j.semnuclmed.2020.12.007","article-title":"FDG PET\/CT for detection of infectious complications following solid organ transplantation.","volume":"51","author":"Wareham","year":"2021","journal-title":"Semin Nucl Med."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1007\/s00259-020-05162-6","article-title":"Diagnostic value of [18F]FDG-PET\/CT in polymyalgia rheumatica: a systematic review and meta-analysis.","volume":"48","author":"van der Geest","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.551684","article-title":"Recent advances in imaging for diagnosis, monitoring, and prognosis of psoriatic arthritis.","volume":"7","author":"Fassio","year":"2020","journal-title":"Front Med (Lausanne)."},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1007\/s40134-020-00367-x","article-title":"Acute findings on FDG PET\/CT: key imaging features and how to differentiate them from malignancy.","volume":"8","author":"Li","year":"2020","journal-title":"Curr Radiol Rep."},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9030890","article-title":"In which patients with sarcoidosis is FDG PET\/CT indicated?","volume":"9","author":"Keijsers","year":"2020","journal-title":"J Clin Med."},{"key":"B113","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/joim.12813","article-title":"FDG-PET\/CT in the management of lymphomas: current status and future directions.","volume":"284","author":"El-Galaly","year":"2018","journal-title":"J Intern Med."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1007\/s00259-018-3973-8","article-title":"FDG-PET\/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC.","volume":"45","author":"Slart","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B115","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1053\/j.semnuclmed.2017.11.004","article-title":"Fever of unknown origin: the value of FDG-PET\/CT.","volume":"48","author":"Kouijzer","year":"2018","journal-title":"Semin Nucl Med."},{"key":"B116","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.cpet.2014.07.002","article-title":"FDG-PET\/CT in infectious and inflammatory diseases.","volume":"9","author":"Hess","year":"2014","journal-title":"PET Clin."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1248\/cpb.35.1036","article-title":"Studies on griseolic acid derivatives. IV. Synthesis and phosphodiesterase inhibitory activity of acylated derivatives of griseolic acid.","volume":"35","author":"Murofushi","year":"1987","journal-title":"Chem Pharm Bull (Tokyo)."},{"key":"B118","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/00006199-198509000-00004","article-title":"The employment potential of hemodialysis patients.","volume":"34","author":"Ferrans","year":"1985","journal-title":"Nurs Res."},{"key":"B119","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1016\/j.metabol.2017.01.011","article-title":"Artificial intelligence in medicine.","author":"Hamet","year":"2017","journal-title":"Metabolism."},{"key":"B120","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1148\/rg.2017170077","article-title":"Deep learning: a primer for radiologists.","volume":"37","author":"Chartrand","year":"2017","journal-title":"Radiographics."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/j.jid.2020.02.026","article-title":"Artificial intelligence in dermatology: a primer.","volume":"140","author":"Young","year":"2020","journal-title":"J Invest Dermatol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jaip.2021.09.014","article-title":"Deep neural network for early image diagnosis of Stevens-Johnson syndrome\/toxic epidermal necrolysis.","volume":"10","author":"Fujimoto","year":"2022","journal-title":"J Allergy Clin Immunol Pract."},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-99370-1","article-title":"Clinical parameters and biological markers associated with acute severe ocular complications in Stevens-Johnson syndrome and toxic epidermal necrolysis.","volume":"11","author":"Panpruk","year":"2021","journal-title":"Sci Rep."},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3390\/biom11060847","article-title":"Chemokines in severe cutaneous adverse reactions (SCARs).","volume":"11","author":"Miyagawa","year":"2021","journal-title":"Biomolecules."},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-76064-8","article-title":"Predictive biomarkers for the progression of ocular complications in chronic Stevens-Johnson syndrome and toxic eeidermal necrolysis.","volume":"10","author":"Yoshikawa","year":"2020","journal-title":"Sci Rep."},{"key":"B126","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/ced.13213","article-title":"Serum IL-17 in patients with erythema multiforme or Stevens-Johnson syndrome\/toxic epidermal necrolysis drug reaction, and correlation with disease severity.","volume":"42","author":"Morsy","year":"2017","journal-title":"Clin Exp Dermatol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/1547691X.2019.1695985","article-title":"Altered levels of complement components associated with non-immediate drug hypersensitivity reactions.","volume":"17","author":"Wang","year":"2020","journal-title":"J Immunotoxicol."},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax2398","article-title":"Neutrophils initiate and exacerbate Stevens-Johnson syndrome and toxic epidermal necrolysis.","volume":"13","author":"Kinoshita","year":"2021","journal-title":"Sci Transl Med."},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaw6142","article-title":"Plasma exosomal miR-375-3p regulates mitochondria-dependent keratinocyte apoptosis by targeting XIAP in severe drug-induced skin reactions.","volume":"12","author":"Zhang","year":"2020","journal-title":"Sci Transl Med."},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0167402","article-title":"Plasma Lipid profiling of patients with chronic ocular complications caused by Stevens-Johnson syndrome\/toxic epidermal necrolysis.","volume":"11","author":"Saito","year":"2016","journal-title":"PLoS One."},{"key":"B131","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1111\/1346-8138.15968","article-title":"Neutrophil : lymphocyte ratio is associated with disease severity and mortality in patients with Stevens-Johnson syndrome\/toxic epidermal necrolysis.","volume":"48","author":"Wang","year":"2021","journal-title":"J Dermatol."},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.311.7003.485","article-title":"Statistics notes: absence of evidence is not evidence of absence.","volume":"311","author":"Altman","year":"1995","journal-title":"BMJ."},{"key":"B133","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/j.jid.2017.07.828","article-title":"New evidence supporting cyclosporine efficacy in epidermal necrolysis.","volume":"137","author":"Roujeau","year":"2017","journal-title":"J Invest Dermatol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.901401\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T06:03:16Z","timestamp":1662962596000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.901401\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,12]]},"references-count":133,"alternative-id":["10.3389\/fmed.2022.901401"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.901401","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,12]]},"article-number":"901401"}}